1 |
Hayashida, K., Parks, W. C. and Park, P. W. (2009) Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 114, 3033-3043.
DOI
ScienceOn
|
2 |
Maxhimer, J. B., Quiros, R. M., Stewart, R., Dowlatshahi, K., Gattuso, P., Fan, M., Prinz, R. A. and Xu, X. (2002) Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery 132, 326-333.
DOI
ScienceOn
|
3 |
Purushothaman, A., Uyama, T., Kobayashi, F., Yamada, S., Sugahara, K., Rapraeger, A. C. and Sanderson, R. D. (2010) Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 115, 2449-2457.
DOI
ScienceOn
|
4 |
Su, G., Blaine, S. A., Qiao, D. and Friedl, A. (2008) Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation. Cancer Res. 68, 9558-9565.
DOI
ScienceOn
|
5 |
Nikolova, V., Koo, C. Y., Ibrahim, S. A., Wang, Z., Spillmann, D., Dreier, R., Kelsch, R., Fischgräbe, J., Smollich, M., Rossi, L. H., Sibrowski, W., Wülfing, P., Kiesel, L., Yip, G. W. and Gotte, M. (2009) Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis 30, 397-407.
DOI
ScienceOn
|
6 |
Yang, Y., Macleod, V., Miao, H. Q., Theus, A., Zhan, F., Shaughnessy, J. D., Jr, Sawyer, J., Li, J. P., Zcharia, E., Vlodavsky, I. and Sanderson, R. D. (2007) Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J. Biol. Chem. 282, 13326-13333.
DOI
ScienceOn
|
7 |
Beauvais, D. M., Ell, B. J., McWhorter, A. R. and Rapraeger, A. C. (2009) Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J. Exp. Med. 206, 691-705.
DOI
ScienceOn
|
8 |
Sanderson, R. D., Yang, Y., Kelly, T., MacLeod, V., Dai, Y. and Theus, A. (2005) Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J. Cell Biochem. 96, 897-905.
DOI
ScienceOn
|
9 |
Subramanian, S. V., Fitzgerald, M. L. and Bernfield, M. (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J. Biol. Chem. 272, 14713-14720.
DOI
ScienceOn
|
10 |
Ding, K., Lopez-Burks, M., Sanchez-Duran, J. A., Korc, M. and Lander, A. D. (2005) Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J. Cell Biol. 171, 729-738.
DOI
ScienceOn
|
11 |
Wang, F., Reierstad, S. and Fishman, D. A. (2006) Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Cancer Lett. 236, 292-301.
DOI
ScienceOn
|
12 |
Wang, J. B., Guan, J., Shen, J., Zhou, L., Zhang, Y. J., Si, Y. F., Yang, L., Jian, X. H. and Sheng, Y. (2009) Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 86, 83-88.
DOI
ScienceOn
|
13 |
Reizes, O., Goldberger, O., Smith, A. C., Xu, Z., Bernfield, M. and Bickel, P. E. (2006) Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: a proposed mechanism for stabilization of extracellular lipoprotein lipase. Biochemistry 45, 5703-5711.
DOI
ScienceOn
|
14 |
Kliment, C. R., Englert, J. M., Gochuico, B. R., Yu, G., Kaminski, N., Rosas, I. and Oury, T. D. (2009) Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J. Biol. Chem. 284, 3537-3545.
DOI
ScienceOn
|
15 |
Rodríguez-Manzaneque, J. C., Carpizo, D., Plaza-Calonge, Mdel. C., Torres-Collado, A. X., Thai, S. N., Simons, M., Horowitz, A. and Iruela-Arispe, M. L. (2009) Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion. Int. J. Biochem. Cell. Biol. 41, 800-810.
DOI
ScienceOn
|
16 |
Holen, I., Drury, N. L., Hargreaves, P. G. and Croucher, P. I. (2001) Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells. Br. J. Haematol. 114, 414-421
DOI
ScienceOn
|
17 |
Endo, K., Takino, T., Miyamori, H., Kinsen, H., Yoshizaki, T., Furukawa, M. and Sato, H. (2003) Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 278, 40764-40770.
DOI
ScienceOn
|
18 |
Asundi, V. K., Erdman, R., Stahl, R. C. and Carey, D. J. (2003) Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells. J. Neurosci. Res. 73, 593-602.
DOI
ScienceOn
|
19 |
Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, G. and Bernfield, M. (2000) Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3-Sensitive Metalloproteinase. J. Cell Biol. 148, 811-824.
DOI
|
20 |
Pruessmeyer, J., Martin, C., Hess, F. M., Schwarz, N., Schmidt, S., Kogel, T., Hoettecke, N., Schmidt, B., Sechi, A., Uhlig, S. and Ludwig, A. (2010) A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation- induced shedding of syndecan-1 and -4 by lung epithelial cells. J. Biol. Chem. 285, 555-564.
DOI
ScienceOn
|
21 |
Spencer, J., Murphy, L. M., Conners, R., Sessions, R. B. and Gamblin, S. J. (2010) Crystal Structure of the LasA Virulence Factor from Pseudomonas aeruginosa: Substrate Specificity and Mechanism of M23 Metallopeptidases. J. Mol. Biol. 396, 908-923.
DOI
ScienceOn
|
22 |
Park, H., Kim, Y., Lim, Y., Han, I. and Oh, E. S. (2002) Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J. Biol. Chem. 277, 29730-29736.
DOI
ScienceOn
|
23 |
Park, P. W., Pier, G. B., Preston, M. J., Goldberger, O., Fitzgerald, M. L. and Bernfield, M. (2000) Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J. Biol. Chem. 275, 3057-3064.
DOI
ScienceOn
|
24 |
Oh, J. H., Kim, J. H., Ahn, H. J., Yoon, J. H., Yoo, S. C., Choi, D. S., Lee, I. S., Ryu, H. S. and Min, C. K. (2009) Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB. Gynecol. Oncol. 114, 509-515.
DOI
ScienceOn
|
25 |
Conejo, J. R., Kleeff, J., Koliopanos, A., Matsuda, K., Zhu, Z. W., Goecke, H., Bicheng, N., Zimmermann, A., Korc, M., Friess, H., and Buchler, M. W. (2000) Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int. J. Cancer 88, 12-20.
DOI
ScienceOn
|
26 |
Popovic, A., Demirovic, A., Spajic, B., Stimac, G., Kruslin, B. and Tomas, D. (2010) Expression and prognostic role of syndecan-2 in prostate cancer. Prostate Cancer Prostatic. Dis. 13, 78-82.
DOI
ScienceOn
|
27 |
Woods, A. and Couchman, J. R. (2001) Syndecan-4 and focal adhesion function. Curr. Opin. Cell Biol. 13, 578-583.
DOI
ScienceOn
|
28 |
Brule, S., Charnaux, N., Sutton, A., Ledoux, D., Chaigneau, T., Saffar, L. and Gattegno, L. (2006) The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology 16, 488-501.
DOI
ScienceOn
|
29 |
Morgan, M. R., Humphries, M. J. and Bass M. D. (2007) Synergistic control of cell adhesion by integrins and syndecans. Nat. Rev. Mol. Cell Biol. 8, 957-969.
DOI
ScienceOn
|
30 |
Chen, P., Abacherli, L. E., Nadler, S. T., Wang, Y., Li, Q. and Parks, W. C. (2009) MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation. PLoS One 4, e6565.
DOI
ScienceOn
|
31 |
Khotskaya, Y. B., Dai, Y., Ritchie, J. P., MacLeod, V., Yang, Y., Zinn, K. and Sanderson, R. D. (2009) Syndecan- 1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in vivo. J. Biol. Chem. 284, 26085-26095.
DOI
ScienceOn
|
32 |
Maeda, T., Desouky, J. and Friedl, A. (2006) Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene 25, 1408-1412.
DOI
ScienceOn
|
33 |
Shimada, K., Nakamura, M., De Velasco, M. A., Tanaka, M., Ouji, Y., Miyake, M., Fujimoto, K., Hirao, K. and Konishi, N. (2010) Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma. Cancer Sci. 101, 155-160.
DOI
ScienceOn
|
34 |
Davies, E. J., Blackhall, F. H., Shanks, J. H., David, G., McGown, A. T., Swindell, R., Slade, R. J., Martin-Hirsch, P., Gallagher, J. T. and Jayson, G. C. (2004) Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Clin. Cancer Res. 10, 5178-5186.
DOI
ScienceOn
|
35 |
Chen, D., Adenekan, B., Chen, L., Vaughan, E. D., Gerald, W., Feng, Z. and Knudsen, B. S. (2004) Syndecan-1 expression in locally invasive and metastatic prostate cancer. Urology 63, 402-407.
DOI
ScienceOn
|
36 |
Gordon, K. J., Dong, M., Chislock, E. M., Fields, T. A. and Blobe, G. C. (2008) Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis 29, 252-262.
DOI
ScienceOn
|
37 |
Levy, P., Munier, A., Baron-Delage, S., Di Gioia, Y., Gespach, C., Capeau, J. and Cherqui, G. (1996) Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. Br. J. Cancer 74, 423-431.
DOI
ScienceOn
|
38 |
Mannello, F., Tonti, G. A., Medda, V., Pederzoli, A. and Sauter, E. R. (2008) Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer. Cancer Sci. 99, 2160-2169.
DOI
ScienceOn
|
39 |
Finger, E. C., Turley, R. S., Dong, M., How, T., Fields, T. A. and Blobe, G. C. (2008) TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Carcinogenesis 29, 528-535.
DOI
ScienceOn
|
40 |
Koenecke, C., Kumpers, P., Lukasz, A., Dammann, E., Verhagen, W., Gohring, G., Buchholz, S., Krauter, J., Eder, M., Schlegelberger, B. and Ganser, A. (2010) Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML. Ann. Hematol. 89, 459-467.
DOI
|
41 |
Bien, E. and Balcerska, A. (2008) Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers 13, 1-26.
DOI
ScienceOn
|
42 |
Fears, C. Y., Gladson, C. L. and Woods, A. (2006) Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. J. Biol. Chem. 281, 14533-14536.
DOI
ScienceOn
|
43 |
Raucci, A., Cugusi, S., Antonelli, A., Barabino, S. M., Monti, L., Bierhaus, A., Reiss, K., Saftig, P. and Bianchi, M. E. (2008) A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22, 3716-3727.
DOI
ScienceOn
|
44 |
Lambaerts, K., Wilcox-Adelman, S. A. and Zimmermann, P. (2009) The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr. Opin. Cell Biol. 21, 662-669.
DOI
ScienceOn
|
45 |
Fan, H. and Derynck, R. (1999) Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 18, 6962-6972.
DOI
ScienceOn
|
46 |
Najy, A. J., Day, K. C. and Day, M. L. (2008) The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J. Biol. Chem. 283, 18393-18401.
DOI
ScienceOn
|
47 |
Zhang, L., Bukulin, M., Kojro, E., Roth, A., Metz, V. V., Fahrenholz, F., Nawroth, P. P., Bierhaus, A. and Postina, R. (2008) Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J. Biol. Chem. 283, 35507-35516.
DOI
ScienceOn
|
48 |
Zhang, L., Postina, R. and Wang, Y. (2009) Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease. Cell Mol. Life Sci. 66, 3923-3935.
DOI
|
49 |
Kojro, E. and Postina, R. (2009) Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease. J. Alzheimers Dis. 16, 865-878.
DOI
|
50 |
Chandler, A. B., Earhart, A. D., Speich, H. E., Kueter, T. J., Hansen, J., White, M. M. and Jennings, L. K. (2010) Regulation of CD40L (CD154) and CD62P (p-selectin) Surface Expression upon GPIIb-IIIa Blockade of Platelets from Stable Coronary Artery Disease Patients. Thromb. Res. 125, 44-52.
DOI
ScienceOn
|
51 |
Gee, J. M. and Knowlden, J. M. (2003) ADAM metalloproteases and EGFR signalling. Breast Cancer Res. 5, 223-224.
DOI
ScienceOn
|
52 |
Lee, D. C., Sunnarborg, S. W., Hinkle, C. L., Myers, T. J., Stevenson, M. Y., Russell, W. E., Castner, B. J., Gerhart, M. J., Paxton, R. J., Black, R. A., Chang, A. and Jackson, L. F. (2003) TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann. N. Y. Acad. Sci. 995, 22-38.
DOI
ScienceOn
|
53 |
Kveiborg, M., Albrechtsen, R., Couchman, J. R. and Wewer, U. M. (2008) Cellular roles of ADAM12 in health and disease. Int. J. Biochem. Cell Biol. 40, 1685-1702.
DOI
ScienceOn
|
54 |
Hakozaki, A., Yoda, M., Tohmonda, T., Furukawa, M., Hikata, T., Uchikawa, S., Takaishi, H., Matsumoto, M., Chiba, K., Horiuchi, K. and Toyama, Y. (2010) Receptor Activator of NF-{kappa}B (RANK) Ligand Induces Ectodomain Shedding of RANK in Murine RAW264.7 Macrophages. J. Immunol. 184, 2442-2448.
DOI
ScienceOn
|